What does NHS primary care need from industry? In our October NHS Whispers webinar, Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation...
Read More
Richard Johnson (Senior Management Consultant – Innovation, Mtech Access) explores the potential of AI in healthcare and life sciences sectors.
How can our community support NHS leaders to deliver a data-led, people-centric health service? Dr Mark Davies (Global Chief Health Officer, IBM) joined Prof. Phil Richardson (Chair and Chief Innovation...
Read More
What is an AMCP dossier and how are they used in US market access? Drawing on their extensive experience compiling AMCP dossiers, here, our global market access experts explain when, why and how…
On Wednesday 16th August Calum Jones (Senior Consultant – Health Economics, Mtech Access) spoke to Dr George Magrath (CEO, Lexitas) about the use of AI in clinical trials, where and...
Read More
In this webinar, we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President &...
Read More
Building strategic engagement with a changing NHS We invited strategic UK market access and commercialisation teams to join us and our guest speakers for our NHS Transformation Symposium on Tuesday...
Read More
In the second episode of our Global Whispers webinar series, we explored market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) spoke to Shefali Shah...
Read More
What does it take to bring a cannabinoid pharmaceutical to market? On Tuesday 23rd May Clare Foy (Global Market Access Director – Mtech Access) was joined by Michael Sassano (CEO...
Read More
What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
